Rucci Carolyn M., SVP and Chief Legal Officer at Akebia Therapeutics ($AKBA), sold nearly $97,000 worth of shares in three open market transactions over the last year. Her most recent sale occurred on February 2, 2026. These sales rank her 9,633rd among nearly 12,000 insiders, far below the average of $8.6 million per seller across about six transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Rucci Carolyn M. | SVP, Chief Legal Officer | S | Common Stock | 16846 | $1.39 | 641,304.0000 | 274,372,722 | 2.56% | 0.01% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Rucci Carolyn M. | SVP, Chief Legal Officer | S | Common Stock | 25382 | $1.39 | 615,922.0000 | 274,372,722 | 3.96% | 0.01% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Rucci Carolyn M. | SVP, Chief Legal Officer | S | Common Stock | 27544 | $1.39 | 588,378.0000 | 274,372,722 | 4.47% | 0.01% |
| Jan. 30, 2026 | Akebia Therapeutics, Inc. | $AKBA | Rucci Carolyn M. | SVP, Chief Legal Officer | A | Common Stock | 190000 | $0.00 | 658,150.0000 | 274,372,722 | 40.59% | 0.07% |
| Jan. 30, 2026 | Akebia Therapeutics, Inc. | $AKBA | Rucci Carolyn M. | SVP, Chief Legal Officer | A | Stock Option (Right to buy) | 270000 | $0.00 | 270,000.0000 | 274,372,722 | 9999.99% | 0.10% |